PEMF Global is home to the largest library of PEMF related scientific studies on the internet. It is continually growing and is updated every second Sunday with new studies.
*All PEMF Global customers have access to the complete library.
If it’s not third party, it’s biased.
Third party studies are the only objective, nonbiased way to learn more about the profound benefits of PEMF technology.
Finding these studies can be a time consuming and frustrating experience. Lucky for you, we’ve done all the heavy lifting!
We have invested countless hours into scouring the internet and finding true, third party, nonbiased research to share with you and the global PEMF community. These studies are in no way related to any specific product or company. They merely share the results and benefits generated by following particular PEMF parameters and protocols in relation to specific test groups, conditions or physiological processes.
Please note that any individual trying to recreate the results of a study must do so using their own judgment. Results may vary as the PEMF systems used in third party studies may be similar to, but not necessarily equivalent to the PEMF systems available for home use. Many PEMF systems only offer a single frequency, single waveform and limited intensity range, which makes it nearly impossible to recreate parameters employed in third party research.
The Omnium1 offers frequencies in the range of 0.5-28 Hz, 0-120 microTesla and multiple waveforms, allowing users to employ similar parameters to most third party scientific studies.
The brand new 2020 iMRS Prime Trial gives users full control of parameters. For the first time ever, users can choose an exact frequency, delivery method (pulses, breaks), intensity and waveform, making it possible to recreate parameters employed in almost any third party scientific study.
NEW STUDIES ADDED
Title: Pulsed electromagnetic fields after arthroscopic treatment for osteochondral defects of the talus: double-blind randomized controlled multicenter trial
Location in PEMF Global Library: Postoperative Folder, Bone Density, Fractures, Breaks Folder, Athletic Performance Folder
Published: 10 July 2009
Applied Frequencies: 75Hz
Available in: iMRS Prime Trial
Abstract: Osteochondral talar defects usually affect athletic patients. The primary surgical
treatment consists of arthroscopic debridement and microfracturing. Although this is mostly
successful, early sport resumption is difficult to achieve, and it can take up to one year to obtain
clinical improvement. Pulsed electromagnetic fields (PEMFs) may be effective for talar defects after
arthroscopic treatment by promoting tissue healing, suppressing inflammation, and relieving pain.
We hypothesize that PEMF-treatment compared to sham-treatment after arthroscopy will lead to
earlier resumption of sports, and aim at 25% increase in patients that resume sports.
Conclusion: This trial will contribute to the knowledge of the effectiveness of PEMF, and may improve health care of patients with an OD. Given the modality's relatively simple technology and ease of use, it has high potential to provide a safe and effective additional treatment option for ODs of the talus.
Title: Novel protective effects of pulsed electromagnetic field ischemia/reperfusion injury rats
Location in PEMF Global Library: Stroke Folder, Circulation Folder, Nitric Oxide Folder
Applied Frequencies: 4.5 ms pulses at 30 +− 3 Hz
Available in: Omnium1 2.0, iMRS Prime
Abstract: Extracorporeal pulsed electromagnetic field (PEMF) has shown the ability to regenerate tissue by promoting cell proliferation. In the present study, we investigated for the first time whether PEMF treatment could improve the myocardial ischaemia/reperfusion (I/R) injury and uncovered its underlying mechanisms.
Conclusions: In our study, we demonstrated for the first time that extracorporeal PEMF has a novel effect on myocardial I/R injury. The number and function of circulating endothelial progenitor cells (EPCs) were increased in PEMF treating rats. The in vivo results showed that per-treatment of PEMF could significantly improve the cardiac function in I/R injury group. In addition, PEMF treatment also reduced the apoptosis of myocardial cells by up-regulating the expression of anti-apoptosis protein B-cell lymphoma 2 (Bcl-2) and down-regulating the expression of pro-apoptosis protein (Bax). In vitro, the results showed that PEMF treatment could significantly reduce the apoptosis and reactive oxygen species (ROS) levels in primary neonatal rat cardiac ventricular myocytes (NRCMs) induced by hypoxia/reoxygenation (H/R). In particular, PEMF increased the phosphorylation of protein kinase B (Akt) and endothelial nitric oxide synthase (eNOS), which might be closely related to attenuated cell apoptosis by increasing the releasing of nitric oxide (NO). Therefore, our data indicated that PEMF could be a potential candidate for I/R injury.
Title: Pulsed Electromagnetic Field Therapy as a Complementary Alternative for Chronic Pelvic Pain Management in an Interstitial Cystitis/Bladder Pain Syndrome Patient
Location in PEMF Global Library: Bladder Folder, Pain Folder
Published: 27 December 2019
Applied Frequencies: 33Hz
Available in: iMRS Prime Trial
Abstract: Interstitial cystitis/bladder pain syndrome is a chronic pelvic pain condition with no known etiology that affects millions of women and men in the United States. Current management can be aggressive for individuals who are refractory to less invasive options, often resulting in the use of opioid narcotics and/or surgical procedures under general anesthesia, with higher risks and side effects to patients. Pulsed electromagnetic field therapy is a noninvasive therapeutic strategy that is thought to reduce inflammation and pain via alteration of cellular function and microcirculation. This therapy has demonstrated efficacy in management of other chronic pain syndromes including fibromyalgia and chronic low back pain.
Conclusion: Herein, we describe a case of pulsed electromagnetic field therapy for management of interstitial cystitis/bladder pain syndrome that resulted in decreases in pelvic pain, burning with bladder filling, and other non pelvic pain symptoms. This case provides support for a formal clinical trial to evaluate the efficacy of pulsed electromagnetic field therapy for the management of chronic pelvic pain in interstitial cystitis/bladder pain syndrome.
Title: Pulsed electromagnetic field improves cardiac function in response to myocardial infarction
Location in PEMF Global Library: Cardiovascular Folder, Circulation Folder
Published: 30 May 2014
Applied Frequencies: 30 ± 3 Hz
Available in: Omnium1 2.0, iMRS Prime
Abstract: Extracorporeal pulsed electromagnetic field (PEMF) has been shown the ability to improve regeneration in various ischemic episodes. Here, we examined whether PEMF therapy facilitates cardiac recovery in rat myocardial infarction (MI), and the cellular/molecular mechanisms underlying PEMF-related therapy was further investigated. The MI rats were exposed to active PEMF for 4 cycles per day (8 minutes/cycle, 30 ± 3 Hz, 5 mT) after MI induction.
Conclusion: The data demonstrated that PEMF treatment significantly inhibited cardiac apoptosis and improved cardiac systolic function. Moreover, PEMF treatment increased capillary density, the levels of vascular endothelial growth factor (VEGF) and hypoxic inducible factor-1α in infarct border zone. Furthermore, the number and function of circulating endothelial progenitor cells were advanced in PEMF treating rats. In vitro, PEMF induced the degree of human umbilical venous endothelial cells tubulization and increased soluble pro-angiogenic factor secretion (VEGF and nitric oxide). In conclusion, PEMF therapy preserves cardiac systolic function, inhibits apoptosis and triggers postnatal neovascularization in ischemic myocardium.
Want complete access to the library?
Simply purchase an Omnium1 2.0 or iMRS through PEMF Global. Call 1-833-879-7363 for more information.